Researchers discover how brain cells may be hardwired for vulnerability to deadly childhood brain tumour
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related deaths in children and young adults.
Happy first anniversary to the Quebec SmartCare Consortium!
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...
$2 million USD to investigate new approaches for prostate cancer treatment
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...
Simon Rousseau named director of the Canadian Respiratory Research Network
RI-MUHC researcher aims to improve respiratory health of patients with lung infections
RI-MUHC and McGill awarded $5.1 million for infectious disease research
A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...
Canada’s Most Powerful Women: Top 100 Award goes to former doctoral student at the RI-MUHC
Dominique Geoffrion is recognized as a young leader creating meaningful change
Two American Heart Association awards for RI-MUHC research associate
Livia Camargo, PhD, investigates human hypertension in Dr. Rhian Touyz’s laboratory
The 2022 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
An Equity, Diversity and Inclusion Action Plan for the RI-MUHC
The plan prioritizes six groups traditionally underrepresented in research
Gabriella Gobbi honoured by the International College of Neuropsychopharmacology
An RI-MUHC researcher with global outreach, Dr. Gobbi is dedicated to advancing the science for mental health